Thursday, June 29, 2017

Unchained Labs Gets $13M, Buys Trinean

Pleasanton-based Unchained Labs, a developer of tools used in the life sciences industry, said today that it has acquired Trinean, a developer of systems that measure protein, DNA and RNA concentration in biologics and genomics samples. Financial terms of the buy were not disclosed. As part of the acquisition, Unchained Labs said it raised $13M in a Series C funding round, from existing backers Novo Ventures, Canaan Partners and TPG Biotech. Tim Harkness is Founder and CEO of Unchained Labs.